Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation (MANTRA-PAF)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by Danish Heart Foundation.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Jens Cosedis Nielsen, Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT00133211
First received: August 22, 2005
Last updated: October 4, 2011
Last verified: October 2011